Previous Close | 0.5700 |
Open | 0.5700 |
Bid | 0.0000 |
Ask | 0.6000 |
Strike | 7.00 |
Expire Date | 2025-02-21 |
Day's Range | 0.5700 - 0.5700 |
Contract Range | N/A |
Volume | |
Open Interest | 4 |
Key Insights Institutions' substantial holdings in Savara implies that they have significant influence over the...
We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are going to take a look at where Savara Inc. (NASDAQ:SVRA) stands against the other biotech penny stocks. Biotech Stocks in 2024: Growth Prospects, Key Players, and Investment Opportunities In 2024, the healthcare industry has been […]
LANGHORNE, Pa., June 28, 2024--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten offering of 26,246,720 shares of its common stock at a price of $3.81 per share before deducting underwriting discounts and commissions, for total gross proceeds of approximately $100.0 million. All of the securities to be sold in the offering are being sold by Savara. The offering included the following investo